These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3000474)

  • 1. High molecular weight kininogen: localization in the unstimulated and activated platelet and activation by a platelet calpain(s).
    Schmaier AH; Smith PM; Purdon AD; White JG; Colman RW
    Blood; 1986 Jan; 67(1):119-30. PubMed ID: 3000474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High molecular weight kininogen is an inhibitor of platelet calpain.
    Schmaier AH; Bradford H; Silver LD; Farber A; Scott CF; Schutsky D; Colman RW
    J Clin Invest; 1986 May; 77(5):1565-73. PubMed ID: 2422211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains.
    Schmaier AH; Schutsky D; Farber A; Silver LD; Bradford HN; Colman RW
    J Biol Chem; 1987 Jan; 262(3):1405-11. PubMed ID: 2433279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High molecular weight kininogen binds to unstimulated platelets.
    Gustafson EJ; Schutsky D; Knight LC; Schmaier AH
    J Clin Invest; 1986 Jul; 78(1):310-8. PubMed ID: 3722381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma.
    Reddigari S; Kaplan AP
    Blood; 1988 May; 71(5):1334-40. PubMed ID: 2451949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies.
    Berrettini M; Lämmle B; White T; Heeb MJ; Schwarz HP; Zuraw B; Curd J; Griffin JH
    Blood; 1986 Aug; 68(2):455-62. PubMed ID: 3730610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane expression of platelet calpain.
    Schmaier AH; Bradford HN; Lundberg D; Farber A; Colman RW
    Blood; 1990 Mar; 75(6):1273-81. PubMed ID: 2310827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-molecular weight kininogen. A secreted platelet protein.
    Schmaier AH; Zuckerberg A; Silverman C; Kuchibhotla J; Tuszynski GP; Colman RW
    J Clin Invest; 1983 May; 71(5):1477-89. PubMed ID: 6406551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassays of human high and low molecular weight kininogens in plasmas and platelets.
    Kerbiriou-Nabias DM; Garcia FO; Larrieu MJ
    Br J Haematol; 1984 Feb; 56(2):273-86. PubMed ID: 6691922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets.
    Gustafson EJ; Lukasiewicz H; Wachtfogel YT; Norton KJ; Schmaier AH; Niewiarowski S; Colman RW
    J Cell Biol; 1989 Jul; 109(1):377-87. PubMed ID: 2526132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody.
    Reddigari S; Kaplan AP
    J Immunol Methods; 1989 Apr; 119(1):19-25. PubMed ID: 2651524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of thrombin-induced platelet aggregation by high molecular weight kininogen.
    Puri RN; Gustafson EJ; Zhou FX; Bradford H; Colman RF; Colman RW
    Trans Assoc Am Physicians; 1987; 100():232-40. PubMed ID: 3455067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of high molecular weight kininogen on human umbilical vein endothelial cells.
    Schmaier AH; Kuo A; Lundberg D; Murray S; Cines DB
    J Biol Chem; 1988 Nov; 263(31):16327-33. PubMed ID: 2460446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural changes of plasma high molecular weight kininogen after in vitro activation and in sepsis.
    Schmaier AH; Farber A; Schein R; Sprung C
    J Lab Clin Med; 1988 Aug; 112(2):182-92. PubMed ID: 2456360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the procoagulant chain derived from human high molecular weight kininogen (Fitzgerald factor) by human tissue kallikrein.
    Maier M; Austen KF; Spragg J
    Blood; 1983 Aug; 62(2):457-63. PubMed ID: 6553501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of human high molecular weight kininogen by factor XIa in vitro. Effect on structure and function.
    Scott CF; Silver LD; Purdon AD; Colman RW
    J Biol Chem; 1985 Sep; 260(19):10856-63. PubMed ID: 3875612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human neutrophils contain and bind high molecular weight kininogen.
    Gustafson EJ; Schmaier AH; Wachtfogel YT; Kaufman N; Kucich U; Colman RW
    J Clin Invest; 1989 Jul; 84(1):28-35. PubMed ID: 2738152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage.
    Meloni FJ; Gustafson EJ; Schmaier AH
    Blood; 1992 Mar; 79(5):1233-44. PubMed ID: 1536948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation.
    Meloni FJ; Schmaier AH
    J Biol Chem; 1991 Apr; 266(11):6786-94. PubMed ID: 2016293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.